News & Events

The Astrogentix News and Events Center provides members of the media and the public timely and relevant information about our company. In this section you will find information and resources including current and archived Astrogenetix press releases, details on upcoming company events, and exciting business opportunities.

Syndicate content Subscribe to our news feed

Astrogenetix Corporation, a subsidiary of Astrotech Corporation (NASDAQ: ASTC), has entered into a Space Act Agreement (SAA) with NASA, (National Aeronautics and Space Administration). This SAA commits to providing the critical resources needed to continue utilizing the International Space Station (ISS) and to further the development of important on-orbit microgravity vaccines and therapeutic drug experiments....
> Read More

NASA astronauts onboard Space Shuttle Endeavoor’s final mission to the International Space Station (ISS), completed a research payload for Astrogenetix, a commercial biotech company based out of Austin, Texas. The research that returned upon the successful landing of STS-134 this morning is the latest in a series focused on changes that occur to methicillin-resistant Staphylococcus aureus (MRSA) and Salmonella in microgravity....
> Read More

NASA astronauts onboard Space Shuttle Discovery’s final mission to the International Space Station (ISS) will carry out the eleventh scientific payload for Astrogenetix, a commercial biotech company based out of Austin, Texas. The research on STS-133 will focus on changes that occur to methicillin-resistant Staphylococcus aureus (MRSA) in microgravity, which can be targeted to create new vaccines and therapeutics....
> Read More

Space Shuttle Atlantis returned from the International Space Station (ISS) landing at the Kennedy Space Center this morning with the tenth scientific payload for Astrogenetix, a commercial biotech company based out of Austin, Texas. Astrogenetix is conducting research on methicillin-resistant Staphylococcus aureus (MRSA) as part of the ISS National Laboratory Pathfinder Vaccine (NLP-V) missions....
> Read More

Space Shuttle Discovery lifted off from NASA’s Kennedy Space Center this morning, carrying on board the ninth scientific payload for Astrogenetix, a commercial biotech company based out of Austin, Texas. Astrogenetix is conducting the International Space Station National Laboratory Pathfinder Vaccine (NLP-V) missions to take advantage of the unique conditions of microgravity to uncover changes in bacteria which can be targeted to create new vaccines and therapeutics....
> Read More